학술논문
Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
Document Type
Article
Author
Wen, Patrick Y ; Stein, Alexander; van den Bent, Martin; De Greve, Jacques; Wick, Antje; de Vos, Filip Y F L; von Bubnoff, Nikolas; van Linde, Myra E; Lai, Albert; Prager, Gerald W; Campone, Mario; Fasolo, Angelica; Lopez-Martin, Jose A; Kim, Tae Min; Mason, Warren P; Hofheinz, Ralf-Dieter; Blay, Jean-Yves; Cho, Daniel C; Gazzah, Anas; Pouessel, Damien; Yachnin, Jeffrey; Boran, Aislyn; Burgess, Paul; Ilankumaran, Palanichamy; Gasal, Eduard; Subbiah, Vivek
Source
In The Lancet Oncology January 2022 23(1):53-64
Subject
Language
ISSN
1470-2045